Albanell J, Martinez MT, Ramos M, O'Connor M, et al. Randomized phase II study of fulvestrant plus palbociclib or placebo in endocrine-sensitive, hormone receptor-positive/HER2-advanced breast cancer: GEICAM/2014-12 (FLIPPER). Eur J Cancer 2021;161:26-37.
PMID: 34902765